Thus, genetic or acquired factors which perturb activities of these processing and degrading enzymes may alter IAPP:INS ratio to increase risk of IAPP oligomerization, fibril formation, beta cell dysfunction and T2D [41]. This evidence concerns the gene IAPP and type 2 diabetes mellitus.